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Abstract
Background: Spondias mombin L. (Anacardiaceae) leaves were used in Togolese folk to treat dystocia, expel placenta and manage 
post-partum hemorrhage during child birth.
Objectives: This study aimed to establish how the extract of S. mombin leaves increase uterine smooth muscle contractions rel-
evant to its traditional use to facilitate child birth.
Methods: Tests were performed on uterus muscle strips from Sprague-Dawley rats. Central portion of  uterine horns were dis-
sected, cleaned of  surrounding fat and loose connective tissue, and cut longitudinally into strips which were placed in the organ 
bath for isometric tension record in presence of  different substances.
Results: S. mombin leaves extract increased uterine spontaneous contractions. This effect was reduced by indomethacin (2 x 10-6 
M), yohimbine (2 x 10-6 M) and 2-aminoethoxydiphenyl borate (2-APB) (5 x 10-5 M), but not by atropine (3.45 x 10-8 M) and 
cholesterol (2.5 mg/ml).
Conclusion: The pharmacological justification for the traditional use of  S. mombin leaves to treat dystocia and expel placenta 
was that its hydro-ethanolic extract induced prostaglandins release, α2-adrenoceptors stimulation, calcium release from internal 
stores and lifted inhibitory effect of  cholesterol on uterine contractions in order to increase uterine smooth muscle contractions.
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Uterotonic agents were recognized to increase uterine 
contractions, not only by intracellular calcium enhance-
ment but also by calcium sensitivity rising at the time of  
uterine contractile force production during a mechanism 
involving G protein-coupled receptors1. Some plants 
were reputed to have uterotonic effect and thus allowed 
calcium mobilization in order to induce uterine smooth 
muscle contraction. Among them, the fresh leaves of  
Spondias mombin were crushed and used traditionally in 
Togo by healers to treat dystocia and manage post-par-
tum hemorrhage2 and to expel placenta in Nigeria3. In 
our previous study, we have shown that hydro-ethanolic 
extract of  S. mombin leaves could contract uterus smooth 
muscle by cytosolic calcium rising. Calcium mobilization 
through muscular contraction process is realized by the 
binding of  a ligand to a membrane receptor or to calcium 
channel or again by membrane depolarization. Membrane 
receptors implied in the signaling of  calcium transduction 
in the time of  smooth muscle contraction were, in many 
cases, attributed to the stimulation of  G protein-coupled 
receptors (GPCRs)4,5.
Several membrane receptors of  GPCRs group were iden-
tified on myometrium membrane and were implied in 
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uterine muscle contraction such as oxytocin receptors6, 
M2 and M3 muscarinic receptors7, α1, α2 and β2 adreno-
ceptors8,9,10, prostaglandin F2α receptors11 and estrogenic 
receptors12. Indomethacin is a cyclo-oxygenase inhibitor 
which blocks prostaglandins synthesis13 and uterine con-
tractions14. Acetylcholine is an agonist of  muscarinic re-
ceptors and causes uterine contraction which is blocked 
by a muscarinic competitive antagonist such as atropine15. 
Yohimbine is a non-selective antagonist of  α2 adrener-
gic receptors16. The binding of  uterotonic agents to these 
receptors initiates uterine contraction4. Also, the binding 
of  uterotonic agents such as oxytocin, activates phospho-
lipase A2 which induces the production of  arachidonic 
acid. The latter promotes the synthesis of  prostaglandins, 
an important uterotonic agent17. 2-aminoethoxydiphenyl 
borate (2-APB) is an inhibitor of  inositol-1,4,5-triphos-
phate (IP3) receptors and prevents calcium release from 
sarcoplasmic reticulum18,19. Cholesterol induced a de-
crease of  uterine smooth muscle contractions and was 
involved in uterus relative quiescent during pregnancy20.
It was shown that methanolic fraction of  S. mombin leaves 
extract had uterotonic activity3 just as hydro-ethanolic ex-
tract21. Hydro-ethanolic extract also possessed an estro-
genic activity22.
The aim of  this work was to examine the effects of  hy-
dro-ethanolic extract of  S.mombin leaves on prostaglan-
dins synthesis or release, calcium release from internal 
stores and calcium mobilization through adrenergic or 
muscarinic receptors in order to elucidate its mechanism 
of  action on uterine smooth muscle contractions relevant 
to its traditional use to facilitate child birth. For that, in 
vitro tests were performed on rat uterine strips muscle to 
search the extract effects on this muscle in the presence 
of  indomethacin, yohimbine, 2-APB and atropine.
Materials and methods
Plant extraction
Spondias mombin leaves were collected in July 2015 in 
Adéticopé village located 15 Km in north of  Lomé city 
(Togo). The leaves were identified to J.F. Brunel collection 
and deposited under voucher specimens sample number: 
TOGO 01851 in Biology and Vegetal Ecology Laborato-
ry herbarium, University of  Lomé, Togo.
Leaves (180 g) were washed, dried under air conditioning 
and were ground. The powder obtained was macerated in 
water/ethanol 95° mixture in the ratio of  1:1 for 72 hours 
under intermittent agitation. The mixture was filtered be-
fore on cotton and after on filter paper. After filtration, 
solvent was evaporated by using a rotary vacuum evap-
orator (R-210 BUCHI) and the extract was obtained as 
powder. This hydro-ethanolic dry extract yields approxi-
mately 21.7% from original dry leaves.
  
Animals care and management
Experiments were carried on adult Sprague-Dawley rats 
weighing 110-180 g. They were bred in Department of  
Physiology Animal (University of  Lome-Togo) where 
they were housed under standard conditions of  light (12 
hours’ cycles), temperature and tap water ad libitum. This 
study was conducted in accordance with institutional 
guidelines and ethics of  Laboratory of  Physiology/Phar-
macology of  University of  Lome-Togo (ref: 001/2012/
CB-FDS-UL). The animals were humanely killed before 
by anesthetic ether and after by cervical dislocation. 
 
Drugs and chemicals
All chemicals used were reagents obtained from Sig-
ma Chemical Company, St Louis, USA.
Soluble cholesterol, Atropine sulfate, Yohimbine hydro-
chloride and 2-aminoethoxydiphenyl borate (2-APB) 
were also purchased from Sigma Chemical Company, 
St Louis, USA. Acetylcholine chloride and Indometha-
cin were obtained from Abbot, France. All physiological 
solutions were prepared on the day of  the experiment.
Experimental design
Female rats were mated with male rats to trigged œstrus 
cycle, and 24 hours after the mating, females were sacri-
ficed by cervical dislocation after ether anesthesis. Cen-
tral portion of  uterine horns were dissected, cleaned of  
surrounding fat and loose connective tissue, and cut lon-
gitudinally into strips (5 mm long, 3 mm wide). Muscle 
strips were maintained in 10 ml organ baths containing 
Krebs-Henseleit solution, (mM): NaCl 118; KCl 4.7; 
CaCl2 2.5; KH2PO4 2.5; MgSO4 1.2; NaHCO3 25; glu-
cose 11; pH 7.4. The solution was continuously aerated 
by Carbogen (95 % O2, 5 % CO2). The isometric con-
tractile force of  the uterine preparations was recorded 
by using a transducer connected to a recorder (BIOPAC 
System MP100). The organ was before preloaded (0.5 g) 
and after an equilibration and a stabilization of  sponta-
neous contractions period of  1 h, the basic tension as 
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well as the spontaneous contractions were continuously 
recorded. Different volumes of  extract were added to the 
organ bath cumulative manner (5 μl; 10 μl; 15 μl; 20 μl 
and 25 μl). Those volumes give respectively 0.05 mg/ml; 
0.15 mg/ml; 0.30 mg/ml; 0.50 mg/ml and 0.75 mg/ml 
as final concentration of  extract. Thus, the effect of  the 
extract on uterine tissue was studied in presence of  indo-
methacin (2 x 10-6 M) or yohimbine (2 x 10-6 M) or 2-APB 
(5 x 10-5 M) or atropine (3.45 x 10-8 M).
  
Data analysis
Data were expressed as mean ± S.E.M. This data was 
processed by using GraphPad Prism 5 software. Statis-
tical significant of  means was determined using Analysis 
of  Variance (ANOVA) followed by Dunnett test. p values 
smaller than 0.05 were considered to be significant.
Results
Effect of  extract on uterine smooth muscle in pres-
ence of  indomethacin
The extract induced an increase of  uterine spontaneous 
contraction amplitude (Fig. 1 A). The maximum increase 
of  uterine contractions was observed with 0.30 mg/ml 
(62.94 ± 16.44 %). The pre-treatment of  uterus with 2 x 
10-6 M of  indomethacin (INDO) was prevented increase 
in uterine contractions induced by cumulative addition 
of  extract (Sm). Thus, the amplitude of  contractions was 
2.98 ± 1.62 and 8.31 ± 3.83 % with 0.15 mg/ml and 0.30 
mg/ml of  extract respectively, compared to the control 
(Fig. 1 B). Likewise, the increase of  uterine spontaneous 
contractions by 0.30 mg/ml of  extract was inhibited by 
a post-treatment of  indomethacin (2 x 10-6 M) (Fig. 1 C).
Effect of  extract on uterus pre-treated by yohimbine
The cumulative concentrations of  extract didn’t augment 
uterine spontaneous contractions in presence of  yohim-
bine (YO) at 2 x 10-6 M. The amplitude of  contractions 
obtained was 3.83 ± 2.76 % and 5.06 ± 2.13 % respec-
tively at 0.15 mg/ml and 0.30 mg/ml of  extract in the 
presence of  yohimbine, compared to the positive control 
(Fig. 2 A). Likewise, the increase of  uterine spontaneous 
contractions by 0.30 mg/ml of  extract was reduced by 2 
x 10-6 M of  yohimbine (Fig. 2 B).
Figure 1. Inhibitory effect of indomethacin on uterus smooth muscle contractions induced by the 
extract.  Values are given as means ± S.E.M. (n = 5) *p < 0.05 (ANOVA followed by Dunnett). Arrow 
show the time of extract or indomethacin addition to the organ bath followed by the wash out. 
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Effect of  extract on uterine smooth muscle in pres-
ence of  2-APB
The augmentation of  spontaneous contractions of  uter-
ine smooth muscle by the extract was reduced by the ad-
dition of  50 µM of  2-APB (Fig. 3A). Not only, the am-
plitude of  contractions was reduced but also the basal 
tone was decreased. When, the uterus strip was mount-
ed in calcium free solution containing 2 mM of  EDTA, 
no contraction of  uterine muscle was observed. In these 
conditions, the extract didn’t augment the spontaneous 
contractions after 2-APB addition (Fig. 3 B).   
Figure 2. Inhibitory effect of yohimbine on uterus smooth muscle contractions induced by the 
extract.  Values are given as means ± S.E.M. (n = 5) *p < 0.05 (ANOVA followed by Dunnett). 
Arrow show the time of extract or yohimbine addition to the organ bath followed by the wash out.
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Effect of  extract on uterine smooth muscle pretreat-
ed by atropine
Uterine contractions were reduced by 3.45 x 10-8 M of  at-
ropine (ATR) and increased by cumulative addition of  ex-
tract (Fig. 4 A). Amplitude of  contractions was increased 
significantly (p < 0.05) with cumulative concentrations of  
extract in the presence of  atropine. We obtained 45.27 ± 
13.6 %; 45.67 ± 6.63 and 41.06 ± 4.71 % increase of  uter-
ine contractions, respectively, at 0.30 mg/ml; 0.50 mg/
ml and 0.75 mg/ml of  extract after atropine action, in 
related to the positive control (Fig. 4 B).
Figure 3. Inhibitory effect of 2-APB on uterus smooth muscle contractions induced by the extract. Arrow 
show the time of extract or calcium free / EDTA solution or 2-APB addition to the organ bath followed by the 
wash out.
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Effect of  extract on uterine smooth muscle in pres-
ence of  cholesterol
Cholesterol (Chol) at 2.5 mg/ml was significantly reduced 
(p < 0.01) the amplitude of  uterine spontaneous con-
tractions (Fig. 5A). The extract (Sm) at 0.30 mg/ml has 
lifted this inhibitory effect of  cholesterol and induced a 
significant increase (p < 0.01) of  the amplitude of  uter-
ine smooth muscle contractions (Fig. 5B). Thus, in the 
presence of  cholesterol, the extract still exerts it effect on 
uterine smooth muscle.  
Discussion
In the present study, we have shown that hydro-ethanolic 
extract of  S. mombin leaves induced a contractile effect 
on uterus. Thus, the extract possessed uterotonic activ-
ity. Some receptors or channels are mediated uterotonic 
agents action on uterine contractions. Among them, we 
distinguish prostaglandins, muscarinic, α1and α2-adreno-
ceptors.
Indomethacin is a cyclo-oxygenase inhibitor which blocks 
prostaglandins synthesis13 and consequently uterine con-
tractions14. The reducing of  uterine force of  contrac-
tions in the presence of  S. mombin leaves extract after a 
Figure 4. Ineffective effect of atropine on uterus smooth muscle contractions induced by the extract. Values 
are given as means ± S.E.M. (n = 4) *p < 0.05 (ANOVA followed by Dunnett). Arrow show the time of 
atropine or extract addition.
Figure 5. Cholesterol inhibits uterine spontaneous contractions (A) and the extract lifts the inhibitory effect 
of cholesterol on uterus smooth muscle contractions (B). Arrow show the time of cholesterol or extract 
addition.
African Health Sciences Vol 18 Issue 2, June, 2018240
treatment with indomethacin, suggested that the extract 
contracted uterus by stimulating the synthesis or releasing 
of  prostaglandins. Veale et al.23 have observed the same 
result with Agapanthus africanus leaves extract on rat uter-
us. Indeed, uterine smooth muscle expressed prostaglan-
dins F2α and prostaglandins E2 receptors, which were 
involved in uterine contractions24. The increasing of  local 
production of  prostaglandins induces uterine contraction 
stimulation5.
It has been shown that uterine smooth muscle contains 
two types of  adrenergic receptors: α-receptors whose 
stimulation induces contraction and β2-receptors which, 
by activation, cause uterine smooth muscle relaxation9. 
Uterus contains particularly α1, α2 and β2 sub-types9. 
Yohimbine is a non-selective antagonist of  α2-adrener-
gic receptors16. The addition of  yohimbine to the organ 
bath before or after extract reduced uterine spontaneous 
contractions. We suggested that the extract goes through 
α2-adrenoceptors to induce uterine contraction. This re-
sult is similar to that of  Uchendu and Leek25 who have 
shown that atipamezole, another α2-adrenoceptors an-
tagonist, reduced uterine contractions induced by the 
root extract of  Dalbergia saxatilis. This result confirms 
also our previous study which showed an inhibition of  
extract effect on uterine smooth muscle by vérapamil. In-
deed, Michel et al.26 have proved that verapamil was also 
an antagonist of  α-adrenoceptors and, in addition, ver-
apamil is often used as L-type calcium channels blocker27.
In our previous study, we have shown that the extract 
exhibited tonic contraction of  uterine muscle in calcium 
free solution containing EDTA. This suggests that the 
extract steps in the mobilization of  intracellular calcium 
in the myometrium contraction process20. The reduction 
of  the augmentation of  spontaneous contractions by the 
extract in presence of  2-APB and the inability of  the ex-
tract to augment spontaneous contractions in calcium 
free solution containing EDTA and 2-APB suggested 
that the extract acted on IP3 receptors to release intracel-
lular calcium. This result is similar to that of  Maruyama et 
al.18 and Morales et al.19 which have shown that the addi-
tion of  2-APB in calcium free solution containing EDTA 
abolished spontaneous contractions of  the uterus. These 
authors also explained this effect by the inhibition of  IP3 
receptors which prevent calcium release from sarcoplas-
mic reticulum. 
Smooth muscle of  uterus is rich in cholinergic receptors 
mainly M3 muscarinic type; acetylcholine is an agonist 
of  this receptor and causes uterine contraction which is 
blocked by a muscarinic competitive antagonist such as 
atropine15. Abdalla et al.7 also proved the expression of  
M2 and M3 muscarinic receptors in the uterine contrac-
tion. The increase of  contractile activity of  extract was 
not modified by atropine suggesting that the extract did 
not bind muscarinic receptors to increase cytosolic cal-
cium. A similar effect was obtained by Eno et al.28 who 
showed that atropine did not block oxytocin effect, an 
uterotonic agent, on uterine smooth muscle. Acetylcho-
line enabled to augment cytosolic calcium influx certain-
ly by Voltage Operated Channels (VOCs) and Receptor 
Operated Channels (ROCs)29 and to release calcium from 
intracellular stock30,31.
A lipid accumulation in uterine myocytes is responsible 
of  the non expulsion of  fetus and of  the reducing of  
uterine sensitivity towards the hormonal stimulation32. 
This study shows that the extract limits the inhibitory 
effect of  cholesterol on uterine contractility. This effect 
could be explained by the cholesterol depletion on uterine 
cells membranes by the extract which allows the increase 
of  intracellular calcium in order to augment uterine con-
tractions. Thus, this plant may facilitate the childbirth in 




Hydro-ethanolic extract of  S. mombin leaves contracts 
uterine smooth muscle by its action on force of  sponta-
neous contractions. Prostaglandins synthesis or releasing, 
α2-adrenergic receptors activation and calcium release 
from intracellular stores could involve on uterus contrac-
tion by the extract in order to increase cytosolic calcium. 
This study allows us to justify the traditional use of  S. 
mombin leaves to facilitate childbirth at the moment of  
delivery in case of  placenta retention.
In further studies, we will try to more understand the in-
hibitory effect of  high concentrations of  the extract. By 
using an oxytocic receptor antagonist such as atosiban, 
we will show the oxytocic effect of  the extract. As yohim-
bine is also known to act on 5-hydroxytryptamine (5-HT) 
and dopamine receptors, we will also check out the effect 
of  the extract on these receptors. We will determine the 
bioactive compound witch is responsible of  biological ac-
tivity of  this plant.       
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